The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorFirst Affiliated Hospital Xi'an Jiaotong University

About this trial

The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women.

To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.

Eligibility criteria

Qualifiers

Pregnant women or parturient women confirmed by blood HCG test.

Patients aged 18 years old and above.

Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.

Disqualifiers

Patients without valid telephone numbers.

Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.

Trial design

Treatments tested in this trial

  • Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C

Treatment groups

200,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations